CTNT
Tel Aviv, Israel· Est.
CTNT delivers boutique, end‑to‑end clinical development services with a focus on decentralized trial technologies for pharma and biotech sponsors.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
CTNT delivers boutique, end‑to‑end clinical development services with a focus on decentralized trial technologies for pharma and biotech sponsors.
Technology Platform
CTNT’s decentralized clinical trial platform integrates electronic data capture, remote patient monitoring, tele‑medicine, and real‑time analytics to enable flexible, patient‑centric trial execution.
Opportunities
Growth opportunities include expanding DCT services to new therapeutic areas, targeting emerging biotech sponsors in Europe and the U.S., and forming strategic technology partnerships.
Risk Factors
Key risks involve intense competition from larger global CROs, potential regulatory changes affecting decentralized trial conduct, and reliance on a limited client base.
Competitive Landscape
CTNT competes with major CROs such as IQVIA, PPD, and PRA Health Sciences; its differentiation stems from boutique service, rapid turnaround, and specialized DCT expertise.